Literature DB >> 10482366

Variable phenotype associated with Ser505Asn-activating thyrotropin-receptor germline mutation.

D Führer1, M Mix, P Wonerow, I Richter, H Willgerodt, R Paschke.   

Abstract

Constitutively activating thyrotropin-receptor (TSHR) germline mutations have been identified as a molecular cause of hereditary nonautoimmune hyperthyroidism. To date, seven cases of familial and six cases of sporadic nonautoimmune hyperthyroidism have been described associated with 13 different TSHR germline mutations, with a variable clinical course. We report the case of a 12.3-year-old girl with a history of thyrotoxicosis since the age of 11 months who developed diffuse thyroid hyperplasia at the age of 4.5 years. The patient has required continuous moderate-dose antithyroid medication, to maintain euthyroidism. There were no clinical signs of autoimmune thyroid disease and autoantibodies were negative. An activating germline mutation in the TSHR gene was suspected and was found in TSHR exon 10 (Ser505Asn) but was absent in the girl's mother. This same mutation, was first reported in a patient with severe intrauterine hyperthyroidism with early and progressive goiter development. Our patient had a significantly less severe clinical course with later onset compared to the original patient with the same TSHR germline mutation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482366     DOI: 10.1089/thy.1999.9.757

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  7 in total

1.  Sporadic nonautoimmune neonatal hyperthyroidism due to A623V germline mutation in the thyrotropin receptor gene.

Authors:  Zehra Aycan; Sebahat Yılmaz Ağladıoğlu; Serdar Ceylaner; Semra Cetinkaya; Veysel Nijat Baş; Havva Nur Peltek Kendirici
Journal:  J Clin Res Pediatr Endocrinol       Date:  2010-11-07

2.  2012 European thyroid association guidelines for the management of familial and persistent sporadic non-autoimmune hyperthyroidism caused by thyroid-stimulating hormone receptor germline mutations.

Authors:  R Paschke; M Niedziela; B Vaidya; L Persani; B Rapoport; J Leclere
Journal:  Eur Thyroid J       Date:  2012-10-04

3.  Similarities and differences in the phenotype of members of an Italian family with hereditary non-autoimmune hyperthyroidism associated with an activating TSH receptor germline mutation.

Authors:  F Arturi; E Chiefari; S Tumino; D Russo; S Squatrito; G Chazenbalk; L Persani; B Rapoport; S Filetti
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

4.  Lack of consistent association of thyrotropin receptor mutations in vitro activity with the clinical course of patients with sporadic non-autoimmune hyperthyroidism.

Authors:  J Lueblinghoff; S Mueller; J Sontheimer; R Paschke
Journal:  J Endocrinol Invest       Date:  2009-07-28       Impact factor: 4.256

5.  A family with a novel TSH receptor activating germline mutation (p.Ala485Val).

Authors:  Sema Akcurin; Doga Turkkahraman; Carolyn Tysoe; Sian Ellard; Anne De Leener; Gilbert Vassart; Sabine Costagliola
Journal:  Eur J Pediatr       Date:  2008-01-04       Impact factor: 3.183

6.  Congenital neonatal hyperthyroidism caused by germline mutations in the TSH receptor gene.

Authors:  Jeremy Chester; Deborah Rotenstein; Usanee Ringkananont; Guy Steuer; Beatrice Carlin; Lindsay Stewart; Helmut Grasberger; Samuel Refetoff
Journal:  J Pediatr Endocrinol Metab       Date:  2008-05       Impact factor: 1.634

7.  A new family with an activating mutation (G431S) in the TSH receptor gene: a phenotype discussion and review of the literature.

Authors:  Cæcilie C Larsen; Lefkothea P Karaviti; Victor Seghers; Roy E Weiss; Samuel Refetoff; Alexandra M Dumitrescu
Journal:  Int J Pediatr Endocrinol       Date:  2014-11-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.